|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.110 SAR | -0.42% |
|
+2.45% | -23.30% |
| Capitalization | 6B 1.6B 1.37B 1.29B 1.2B 2.21B 144B 2.41B 15.05B 5.81B 67.9B 5.87B 248B | P/E ratio 2023 |
19.9x | P/E ratio 2024 | 26.8x |
|---|---|---|---|---|---|
| Enterprise value | 7.45B 1.99B 1.71B 1.6B 1.49B 2.75B 179B 2.99B 18.7B 7.22B 84.4B 7.29B 309B | EV / Sales 2023 |
0.98x | EV / Sales 2024 | 1.45x |
| Free-Float |
88.59% | Yield 2023 |
1.16% | Yield 2024 | 0.54% |
More valuation ratios
* Estimated data
More news
| 1 day | -0.42% | ||
| 1 week | +2.45% | ||
| Current month | +2.45% | ||
| 1 month | -6.45% | ||
| 3 months | +11.27% | ||
| 6 months | -5.58% | ||
| Current year | -23.30% |
| 1 week | 6.91 |  | 7.22 |
| 1 month | 6.84 | | 7.8 |
| Current year | 6.06 | | 10.72 |
| 1 year | 6.06 | | 10.72 |
| 3 years | 2.44 | | 12.24 |
| 5 years | 2.44 | | 12.24 |
| 10 years | 1.93 | | 12.24 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 11/11/2020 | |
| Investor Relations Contact | - | - | |
| Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 66 | 01/01/2010 | |
| Director/Board Member | - | 11/05/2010 | |
Obaid Al-Rashid
BRD | Director/Board Member | - | 01/01/2013 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0% | 51 M€ | +4.72% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.42% | +2.45% | -30.84% | +171.37% | 1.6B | |
| -0.68% | -8.23% | +33.98% | +113.90% | 99.81B | |
| -0.18% | -6.33% | +61.97% | +150.42% | 47.24B | |
| +3.26% | -1.04% | - | - | 21.74B | |
| -0.59% | +0.31% | +11.75% | -4.75% | 10.43B | |
| +0.06% | +0.51% | -17.63% | -6.09% | 8.5B | |
| +0.49% | +2.59% | +0.05% | +9.13% | 8.24B | |
| +0.63% | +0.81% | +1.96% | +70.88% | 6.61B | |
| -0.16% | +0.77% | +20.93% | +29.64% | 5.68B | |
| +0.59% | +4.29% | -5.37% | -0.86% | 3.6B | |
| Average | +0.30% | -0.88% | +8.53% | +59.29% | 21.34B | |
| Weighted average by Cap. | -0.01% | -5.23% | +33.15% | +100.96% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 4.85B 1.29B 1.11B 1.04B 971M 1.79B 116B 1.95B 12.18B 4.7B 54.98B 4.75B 201B | 6.38B 1.7B 1.46B 1.37B 1.27B 2.35B 153B 2.56B 16B 6.18B 72.2B 6.24B 264B |
| Net income | 183M 48.73M 41.89M 39.24M 36.57M 67.55M 4.39B 73.48M 459M 177M 2.07B 179M 7.57B | 291M 77.6M 66.7M 62.49M 58.24M 108M 6.98B 117M 731M 282M 3.3B 285M 12.06B |
| Net Debt | 1.09B 291M 250M 234M 218M 403M 26.19B 439M 2.74B 1.06B 12.37B 1.07B 45.23B | 1.46B 388M 334M 313M 291M 538M 34.94B 585M 3.66B 1.41B 16.5B 1.43B 60.34B |
More financial data
* Estimated data
Employees
-
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/12/25 | 7.110 ﷼ | -0.42% | 2,613,870 |
| 04/12/25 | 7.140 ﷼ | +1.85% | 5,018,488 |
| 03/12/25 | 7.010 ﷼ | -0.28% | 3,963,114 |
| 02/12/25 | 7.030 ﷼ | -0.14% | 2,098,878 |
| 01/12/25 | 7.040 ﷼ | +1.44% | 2,645,266 |
Delayed Quote Saudi Arabian S.E., December 07, 2025 at 03:20 pm
More quotes
- Stock Market
- Equities
- 2230 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition